PAUL COLVIN Insider Trading $PPDI PHARMACEUTICAL PRODUCT DEVELOPMENT INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL COLVIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL COLVIN. PAUL COLVIN is EVP--Clinical Development in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Pres., Clinical Solutions in Syneos Health, Inc. ($INCR).
PAUL COLVIN in PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Trading Symbol: PPDIIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of PAUL COLVIN: EVP--Clinical Development
Holdings: 0 shares
Latest Transaction: Dec 06 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PAUL COLVIN in PHARMACEUTICAL PRODUCT DEVELOPMENT INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 0.00 | 10,000 | 0 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 37.51 | 31,052 | 1,164,761 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 43.26 | 15,526 | 671,655 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 37.69 | 11,386 | 429,138 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 25.74 | 15,992 | 411,634 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 26.64 | 16,000 | 426,240 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 27.27 | 30,000 | 818,100 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 20.45 | 11,041 | 225,788 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | D | 19.94 | 3,753 | 74,835 | 0 | |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Sell | D | 33.25 | 45 | 1,496 | 0 | 45 to 0 (-100.00 %) |
Dec 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | I | 24.98 | 20 | 500 | 45 | 25 to 45 (+80.00 %) |
Jul 06 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | I | 24.16 | 24 | 580 | 24 | 0 to 24 |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | M | 20.45 | 5,333 | 109,060 | 11,041 | |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | M | 19.94 | 326 | 6,500 | 3,753 | |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | M | 19.94 | 100 | 1,994 | 4,079 | |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Sell | S | 28.70 | 5,659 | 162,413 | 0 | 5.7 K to 0 (-100.00 %) |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | M | 20.45 | 5,333 | 109,060 | 5,659 | 326 to 5.7 K (+1,635.89 %) |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | M | 19.94 | 326 | 6,500 | 326 | 0 to 326 |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Sell | S | 28.70 | 100 | 2,870 | 0 | 100 to 0 (-100.00 %) |
May 27 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | M | 19.94 | 100 | 1,994 | 100 | 0 to 100 |
May 23 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | M | 20.45 | 187 | 3,824 | 16,374 | |
May 23 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | M | 19.94 | 413 | 8,235 | 4,179 | |
May 23 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Sell | S | 29.01 | 600 | 17,406 | 0 | 600 to 0 (-100.00 %) |
May 23 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | M | 20.45 | 187 | 3,824 | 600 | 413 to 600 (+45.28 %) |
May 23 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Buy | M | 19.94 | 413 | 8,235 | 413 | 0 to 413 |
Feb 25 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Feb 25 2011 | PPDI | PHARMACEUTICAL PRO ... | COLVIN PAUL | EVP--Clinical Devel ... | Option Exercise | A | 27.27 | 30,000 | 818,100 | 30,000 |
Page: 1